Explore › Finding
Finding decline
Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared with term non-SGA births (95% CI 1.12-7.85). MetS overall was marginally elevated (WHO: OR 1.51, 95% CI 0.82-2.60) and glucose impairment was unmasked after BMI adjustment.
Effect sizeOR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile
CI95% CI 1.12, 7.85
ComparatorWomen with term, non-SGA births (>37 weeks, >10th percentile birth weight)
Effect summarydecline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Connected entities

Interventions
Targeted glucose and metabolic screening
Conditions
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome
Outcomes
Glucose Metabolism Disorders
Populations
Postmenopausal Women

Source

PMC3074407
Prior Preterm or Small-for-Gestational-Age Birth Related to Maternal Metabolic Syndrome
Read on PMC → · View in graph →